"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-IV Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism"
written by Yutaka Takeuchi, Masayuki Namiki, Yasumi Kitahara, Setsuo Hasegawa, Akihiro Ohnishi, Nobuyuki Yasuda, Takashi Inoue, Richard Clark, Kazuto Yamazaki,
published by Pharmacology & Pharmacy, Vol.4 No.9, 2013
has been cited by the following article(s):